Overview
Sandfly-borne phleboviral diseases are a group of viral infections transmitted primarily by sandflies (Phlebotomus and Lutzomyia species). These viruses, including Naples, Sicilian, and Toscana viruses, belong to the Bunyaviridae family and are endemic in various regions, particularly in the Mediterranean basin, parts of Africa, and Asia. Epidemiological studies indicate significant public health concerns due to high seroprevalence rates among affected populations, suggesting ongoing transmission and potential for outbreaks. Clinical manifestations can range from mild febrile illness to more severe presentations, often complicating differential diagnosis, especially in endemic areas or among military personnel deployed in affected regions. Understanding the epidemiology, clinical presentation, diagnosis, and management of these infections is crucial for effective public health interventions and clinical management.
Epidemiology
The epidemiology of sandfly-borne phleboviral diseases highlights substantial regional variations and temporal trends influenced by environmental and public health interventions. Studies have shown that neutralizing antibodies to these viruses are prevalent across different populations. For instance, in a study conducted in Italy, neutralizing antibodies were detected in 57%, 32%, and 20% of the population for Naples, Sicilian, and Toscana viruses, respectively [PMID:1661242]. This wide range in seroprevalence underscores the diverse impact of these viruses across different geographical areas. Notably, one study site exhibited significantly higher antibody prevalence to Naples and Sicilian viruses compared to another, indicating localized environmental or behavioral factors that may influence transmission dynamics [PMID:1661242].
In Iran, a significant proportion of military personnel in Ilam province demonstrated SFV-specific IgG antibodies, with 18.4% of 201 serum samples testing positive, predominantly for the Naples and Sicilian serotypes [PMID:27017407]. This finding highlights the vulnerability of specific occupational groups to these infections, emphasizing the need for targeted surveillance and preventive measures in high-risk populations. Additionally, serological studies have revealed a marked decline in Naples and Sicilian Phlebotomus fever virus antibodies among younger individuals (≤29 years old) compared to older residents (≥30 years old) [PMID:190909]. This age-specific trend suggests that interventions such as insecticide spraying, initiated for malaria control in Greece, have effectively reduced vector populations and consequently lowered disease prevalence [PMID:190909]. The correlation between vector control measures and reduced incidence underscores the importance of integrated vector management strategies in controlling sandfly-borne phleboviral diseases.
Clinical Presentation
The clinical presentation of sandfly-borne phleboviral diseases can vary widely, ranging from asymptomatic infections to severe febrile illnesses. Common symptoms include fever, headache, myalgia, arthralgia, and malaise, often mimicking other viral fevers. A notable aspect of these infections is the potential for complex presentations due to co-infections. Studies have indicated a higher frequency of dual and triple infections with different phlebovirus serotypes than would be expected by chance, suggesting that patients may experience overlapping or compounded symptoms [PMID:1661242]. For example, concurrent infections with Naples and Toscana viruses might lead to more pronounced or prolonged febrile episodes and neurological symptoms, complicating clinical diagnosis and management.
In military personnel, the clinical picture can be particularly concerning due to the confined living conditions and potential for rapid spread within units. Acute febrile illness in troops should prompt consideration of SFV infection, given the significant seroprevalence observed in such populations [PMID:27017407]. Neurological complications, including meningitis and encephalitis, though less common, can occur and require prompt recognition and intervention to prevent severe outcomes. The variability in clinical presentations necessitates a thorough history, including travel and occupational exposures, to guide appropriate diagnostic testing and management strategies.
Diagnosis
Diagnosing sandfly-borne phleboviral diseases relies heavily on serological testing due to the nonspecific clinical symptoms. Serological methods, such as enzyme-linked immunosorbent assays (ELISAs) and immunofluorescence assays, are commonly employed to detect specific antibodies against Naples, Sicilian, and Toscana viruses. A key finding from serological studies is that individuals with antibodies to both Naples and Toscana viruses often exhibit elevated antibody levels specifically to Naples virus [PMID:1661242]. This observation can inform diagnostic strategies, guiding clinicians to prioritize Naples virus testing in cases where dual infection is suspected. Additionally, molecular diagnostic techniques, such as reverse transcription polymerase chain reaction (RT-PCR), can be utilized for acute diagnosis, particularly in the early stages of infection when viral RNA is still detectable in blood samples.
In clinical practice, the integration of serological testing with clinical context is crucial. For instance, a positive SFV test in a patient with a history of travel to endemic regions or occupational exposure should be corroborated with clinical symptoms and possibly repeated testing to rule out false positives or recent infections. Given the potential for cross-reactivity and the complexity of co-infections, a comprehensive approach that includes serological panels and molecular diagnostics enhances diagnostic accuracy and timely intervention.
Differential Diagnosis
Differentiating sandfly-borne phleboviral infections from other febrile illnesses is essential for appropriate management. Common differential diagnoses include other arboviral infections (e.g., dengue, chikungunya), rickettsial diseases (e.g., typhus), and bacterial infections (e.g., leptospirosis). The overlap in clinical symptoms, particularly fever and myalgia, necessitates a thorough clinical evaluation, including travel history, occupational exposure, and epidemiological context. Military personnel presenting with acute febrile illness should be particularly scrutinized for SFV infection due to the significant seroprevalence observed in such groups [PMID:27017407]. Laboratory findings, such as leukopenia or thrombocytopenia, can further support the diagnosis but are not pathognomonic.
In endemic regions, clinicians must consider the local epidemiology and vector distribution when formulating a differential diagnosis. For example, in areas where sandfly populations are prevalent, SFV should be high on the list of potential causes of febrile illness, especially if accompanied by neurological symptoms or if there is a history of exposure to sandfly habitats. Collaboration with public health authorities for seroprevalence data and vector surveillance can provide valuable insights, aiding in narrowing down the differential diagnosis and guiding targeted diagnostic testing.
Special Populations
Age-Specific Considerations
Age plays a significant role in the epidemiology of sandfly-borne phleboviral diseases. Studies have shown a marked decline in antibody prevalence among younger individuals (≤29 years old) compared to older residents (≥30 years old), indicating a generational shift in disease exposure [PMID:190909]. Specifically, only 4% of individuals aged ≤29 years had detectable antibodies to Naples virus, contrasting sharply with 36% in those aged ≥30 years [PMID:190909]. This trend suggests that younger populations may have benefited more from recent vector control measures and possibly improved public health interventions. Clinicians should be aware of these age-specific differences when assessing risk and considering preventive strategies, particularly in younger, less exposed populations.
Occupational Risk
Occupational groups, particularly military personnel deployed in endemic regions, exhibit heightened risk for sandfly-borne phleboviral infections. Serological surveys among Iranian military personnel in Ilam province revealed a notable seroprevalence of SFV-specific IgG antibodies, with Naples and Sicilian serotypes being most prevalent [PMID:27017407]. The inverse relationship between nativity and positive SFV tests (P<0.01) further highlights that non-native personnel might be at higher risk due to potentially lower pre-exposure immunity [PMID:27017407]. This underscores the importance of targeted screening and preventive measures for deployed military units, including prophylactic measures and rapid diagnostic capabilities to manage outbreaks effectively.
Gender Differences
Gender does not appear to significantly influence the prevalence of sandfly-borne phleboviral infections based on available evidence. Studies indicate that antibody prevalence rates for Naples, Sicilian, and Toscana viruses are similar between men and women [PMID:1661242]. However, this does not negate the need for gender-specific considerations in clinical management, particularly in terms of symptomatology and response to treatment, which may vary based on individual health profiles and comorbidities rather than gender alone.
Management
The management of sandfly-borne phleboviral diseases primarily focuses on supportive care due to the lack of specific antiviral treatments. Patients typically require symptomatic relief, including antipyretics for fever and analgesics for myalgia and arthralgia. In cases of severe illness, particularly those involving neurological complications such as meningitis or encephalitis, hospitalization may be necessary for close monitoring and supportive interventions like intravenous fluids, anticonvulsants, and corticosteroids if indicated. Early recognition and prompt management are crucial to prevent complications and ensure a favorable outcome.
Preventive Measures
Preventive strategies are essential in controlling the spread of these infections. Vector control remains a cornerstone, involving the use of residual insecticides, environmental management to reduce sandfly breeding sites, and personal protective measures such as the use of insect repellents and bed nets. Public health campaigns should emphasize these preventive practices, especially in endemic areas and among high-risk groups like military personnel and travelers. Vaccines are currently not available for these viruses, highlighting the importance of vector control and personal protection in mitigating risk.
Key Recommendations
By integrating these recommendations into clinical practice and public health initiatives, healthcare providers can better manage and mitigate the impact of sandfly-borne phleboviral diseases in affected communities.
References
1 Eitrem R, Stylianou M, Niklasson B. High prevalence rates of antibody to three sandfly fever viruses (Sicilian, Naples, and Toscana) among Cypriots. Epidemiology and infection 1991. link 2 Shiraly R, Khosravi A, Farahangiz S. Seroprevalence of sandfly fever virus infection in military personnel on the western border of Iran. Journal of infection and public health 2017. link 3 Tesh RB, Papaevangelou G. Effect of insecticide spraying for malaria control on the incidence of sandfly fever in Athens, Greece. The American journal of tropical medicine and hygiene 1977. link